What is the significance of the announced merger with Computer Motion, Inc.?

The merger with Computer Motion, Inc. is a significant strategic move intended to combine complementary technologies, resolve ongoing patent litigations between the two companies, and achieve an estimated $18 million in annual pre-tax cost savings. It aims to consolidate the robotic surgery market and strengthen the combined entity's position.

What were the key financial highlights for the year ended December 31, 2002?

For the year ended December 31, 2002, Intuitive Surgical reported sales of $72.0 million, up 39% from $51.7 million in 2001. This growth was driven by increased system sales and recurring revenue from instruments and services. However, the company incurred a net loss of $18.4 million, reflecting continued investment in operations.

What are the primary risks and uncertainties highlighted by the company?

Key risks include the lengthy and variable sales cycles for the da Vinci Surgical System, the reliance on a few key customers, achieving market acceptance for a new surgical technology, ongoing intellectual property litigation, regulatory hurdles with the FDA, manufacturing complexities, potential defects in products, and integration risks associated with the proposed merger with Computer Motion.

ISRG 10-K Filed May 30, 2003

Q: What is the core business of Intuitive Surgical, Inc. as described in this filing?

Intuitive Surgical, Inc. designs, manufactures, and markets the da Vinci Surgical System, an advanced robotic surgical system that enables surgeons to perform complex minimally invasive procedures with greater precision, dexterity, and 3D visualization compared to traditional open surgery or current minimally invasive techniques.

Summary

Intuitive Surgical, Inc. (ISRG) filed its 2002 10-K amendment on May 29, 2003, reporting on its innovative da Vinci Surgical System. The company's core business revolves around this advanced robotic surgical platform, designed to enhance surgical precision and patient outcomes by enabling surgeons to perform complex minimally invasive procedures with greater dexterity and 3D visualization. As of December 31, 2002, ISRG had sold 149 da Vinci Surgical Systems, demonstrating early market traction. A significant development highlighted is the proposed merger with Computer Motion, Inc., announced on March 7, 2003. This strategic move aims to combine complementary technologies, resolve ongoing patent litigations, and achieve substantial cost synergies. The merger, however, is subject to stockholder approval and carries its own set of integration challenges and risks, including potential dilution to existing ISRG shareholders and the need for significant capital to fund combined operations. Financially, ISRG reported $72.0 million in sales for 2002, a significant increase from $51.7 million in 2001, driven by a rise in system sales and growing recurring revenue from instruments and services. Despite revenue growth, the company continued to operate at a net loss of $18.4 million in 2002, reflecting ongoing investments in research and development and selling, general, and administrative expenses. The company's cash position stood at $50.8 million as of December 31, 2002, and management believes current resources are sufficient to meet liquidity requirements through 2003.

Key Highlights

1The company's primary product is the da Vinci Surgical System, a robotic surgical platform designed to enable advanced minimally invasive surgery with enhanced precision and visualization.

2As of December 31, 2002, 149 da Vinci Surgical Systems had been sold, indicating early adoption and market penetration.

3A significant event is the announced merger with competitor Computer Motion, Inc., aimed at consolidating the robotic surgery market, resolving litigation, and realizing cost synergies.

42002 sales reached $72.0 million, a substantial increase from $51.7 million in 2001, primarily driven by increased system sales and growing recurring revenue from instruments and services.

5Despite revenue growth, the company reported a net loss of $18.4 million for 2002, underscoring continued investment in R&D and sales & marketing.

6As of December 31, 2002, Intuitive Surgical had $50.8 million in cash, cash equivalents, and short-term investments, with management confident in its liquidity through 2003.

7The company is involved in ongoing patent litigation with Brookhill-Wilk 1, LLC and Computer Motion, Inc., which poses potential financial and operational risks, although the merger aims to resolve these disputes.

Frequently Asked Questions